1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Myanmar Pharmaceuticals and Healthcare Report Q2 2016

Myanmar Pharmaceuticals and Healthcare Report Q2 2016

  • March 2016
  • -
  • Business Monitor International
  • -
  • 52 pages

Includes 3 FREE quarterly updates

BMI View: The influx of private healthcare providers into Myanmar will continue, creating positive spillovereffects for both medical device and pharmaceutical firms. This attraction is due to the combination of alarge unmet demand for medical services in the country, as well as the development of healthcare financing,such as the introduction of private medical insurance. Due to its geographic proximity, Thailand-basedhealthcare providers are expected to be the most active in expanding into this frontier market.

Headline Expenditure Projections

- Pharmaceutical sales: MMK458.3bn (USD390mn) in 2015 to MMK536.8bn (USD400mn) in 2015;+17.1% in local currency terms and +2.9% in US dollar terms. Forecast downwards from last quarter.

- Healthcare Expenditure: MMK1,176.8bn (USD1.01bn) in 2015 to MMK1,304.8bn (USD980mn) in2016; +10.9% in local currency terms and -2.6% in US dollar terms. Forecast revised downwards fromlast quarter, growth in USD terms affected by exchange rates.

Table Of Contents

Myanmar Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Myanmar 2014-2020) 7
SWOT 9
Industry Forecast 10
Pharmaceutical Market Forecast 10
Table: Pharmaceutical Sales, Historical Data And Forecasts (Myanmar 2012-2020) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Myanmar 2012-2020) 15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Myanmar 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Myanmar 2012-2020) 16
Pharmaceutical Trade Forecast 17
Table: Pharmaceutical Trade Data And Forecasts (Myanmar 2014-2020) 18
Table: Pharmaceutical Trade Data And Forecasts local currency (Myanmar 2014-2020) 18
Industry Risk Reward Index 19
Asia Pacific Risk/Reward Index 19
Myanmar Risk/Reward Index 25
Rewards 25
Risks 25
Regulatory Review 27
Market Overview 29
Healthcare Sector 29
Research and Development 31
Clinical Trials 31
Epidemiology 31
Communicable Diseases And Other Injuries 32
Non-Communicable Diseases 32
Competitive Landscape 34
Table: Table: Multinational Market Activity 35
Company Profile 36
Fame Pharmaceutical 36
Mega Lifesciences 38
Demographic Forecast 41
Table: Population Headline Indicators (Myanmar 1990-2025) 42
Table: Key Population Ratios (Myanmar 1990-2025) 42
Table: Urban/Rural Population and Life Expectancy (Myanmar 1990-2025) 43
Table: Population By Age Group (Myanmar 1990-2025) 43
Table: Population By Age Group % (Myanmar 1990-2025) 44
Glossary 46
Methodology 48
Pharmaceutical Expenditure Forecast Model 48
Healthcare Expenditure Forecast Model 48
Notes On Methodology 49
Risk/Reward Index Methodology 50
Index Overview 51
Table: Pharmaceutical Risk/Reward Index Indicators 51
Indicator Weightings 52

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.